Safety and tolerability of mirvetuximab soravtansine monotherapy for folate receptor alpha–expressing recurrent ovarian cancer: An integrated safety summary. - Moore, Kathleen N.; Lorusso, Domenica; Oaknin, Ana; Oza, Amit; Colombo, Nicoletta; Van Gorp, Toon; O'Malley, David M.; Banerjee, Susana; Murphy, Conleth G.; Harter, Philipp; Konecny, Gottfried E.; Pautier, Patricia; et al. (Gynecologic Oncology, 2024)